Advertisement

Topics

GENFIT Company Profile

05:10 EST 17th December 2018 | BioPortfolio

GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neurodegenerative disorders (prediabetes/diabetes, atherosclerosis, dyslipidemia, obesity, Alzheimer’s…). GENFIT uses a multi-pronged approach based on early diagnosis, preventive solutions, and therapeutic treatments to address these major public health concerns and their unmet medical needs. GENFIT’s proprietary research programs and its partnerships with leading pharmaceutical companies, including SANOFI-AVENTIS, SOLVAY GROUP, and SERVIER, have resulted in the creation of a rich and diversified pipeline of drug candidates at different stages of development. GENFIT’s lead proprietary compound, GFT505, is currently in Phase II and two other compounds, in partnership with SANOFI-AVENTIS and SOLVAY, are in the advanced stages of Phase I.

Location

Parc Eurasanté – Lille Métropole
885, avenue Eugène Avinée
LOOS
59120
France

Contact

Phone: +33 (0)3 20 16 40 00
Fax: +33 (0)3 20 16 40 01
Email: contact@genfit.com


News Articles [29 Associated News Articles listed on BioPortfolio]

GENFIT completes enrolment in Phase lla trial of elafibranor for PBC

GENFIT has completed patient enrolment in a Phase lla trial to investigate the efficacy and safety of elafibranor for the...Read More... The post GENFIT completes enrolment in Phase lla trial of elafi...

#news #biotech Genfit’s elafibranor hits goal in phase 2 PBC trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genfit’s elafibranor hits goal in phase 2 PBC trial .A phase 2 trial of Gen...

Genfit PBC data end of year http://www.genfit.com/wp-content/uploads/2018/08/2018.08.28-End-of-PBC-enrollment-PR-EN.pdf … $CBAY

Genfit PBC data end of year http://www.genfit.com/wp-content/uploads/2018/08/2018.08.28-End-of-PBC-enrollment-PR-EN.pdf … $CBAY

#PressRelease GENFIT: Positive Phase 2 Results from Study of #Elafibranor in Primary Biliary Cholangitis https://www.genfit.com/wp-content/uploads/2018/12/2018.12.06-PR-PBC.pdf … #PBC #PrimaryBiliaryCholangitis #Autoimmunepic.twitter.com/d0nINSsU62

#PressRelease GENFIT: Positive Phase 2 Results from Study of #Elafibranor in Primary Biliary Cholangitis

Genfit announces plans for #IPO in the US $GNFT #NASH https://globenewswire.com/news-release/2018/11/19/1653382/0/en/GENFIT-ANNOUNCES-PLANS-TO-CONDUCT-REGISTERED-PUBLIC-OFFERING-IN-THE-UNITED-STATES.html …

Genfit announces plans for #IPO in the US $GNFT #NASH https://globenewswire.com/news-release/2018/11/19/1653382/0/en/GENFIT-ANNOUNCES-PLANS-TO-CONDUCT-REGISTERED-PUBLIC-OFFERING-IN-THE-UNITED-STAT...

GENFIT: Positive Phase 2 Results from Study of Elafibranor in Primary Biliary Cholangitis

GENFIT: Positive Phase 2 Results from Study of Elafibranor in Primary Biliary Cholangitis Elafibranor successfully meets primary endpoint with high statistical significance of p<...

NASH company Genfit planning U.S. listing

GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis $GNFT https://globenewswire.com/news-release/2018/12/03/1660476/0/en/GENFIT-Launch-of-a-U-S-Phase-2-investigator-initiated-study-with-ni

GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis $GNFT https://globenewswire.com/news-release/2018/12/03/1660476/0/en/GENFIT-Lau...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

GENFIT

GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neuro...

Bionest Partners Inc.

Bionest Partners Inc. provides strategy consulting services exclusively for the life science industries to help pharmaceutical, biopharmaceutical, diagnostics, biotechnology, and ...

More Information about "GENFIT" on BioPortfolio

We have published hundreds of GENFIT news stories on BioPortfolio along with dozens of GENFIT Clinical Trials and PubMed Articles about GENFIT for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GENFIT Companies in our database. You can also find out about relevant GENFIT Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record